Aquinox Pharma Cash Flow - Annual (NASDAQ:AQXP)

Add to My Stocks
$14.69 $0.12 (0.82%) AQXP stock closing price Mar 16, 2018 (Closing)

The Aquinox Pharma cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows Aquinox Pharma profits, the balance sheet shows Aquinox Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Aquinox Pharma had cash and cash equivalents of $39.52M at beginning of the year and $32.3M at year end for 2016. Aquinox Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. AQXP decrease in investments stood at a value of $-48.05M for the latest year 2016.

View details of Aquinox Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20162015201420132012
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--2.02M--
Net Increase (Decrease) in Assets Liabilities4.7M-0.54M3.59M1.07M-0.04M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net2.07M2.13M--0.73M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.71M-0.02M-0.08M--0.01M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-47.34M-47.5M-23.48M-2.82M-
Other Cash Inflow (Outflow) from Investment Activities-----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares75.8M99.15M53.12M18M-
Issuance (Repayment) of Debt Securities---2.5M2.5M-
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-4.69M-6.21M-5.35M-0.91M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.05M-0.52M---
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year39.52M14.9M11M2M9.23M
Cash & Equivalents at Year End32.3M39.52M14.9M11M2M
All figures in USD. M: Millions of USD, B: Billions of USD.

While Aquinox Pharma stock price history provides the price history of a stock, Aquinox Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Aquinox Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Aquinox Pharma stock price movement.
  • The cash generated from the core business or operations was a negative at $-30.22M for Aquinox Pharma in the latest 2016. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-48.05M for AQXP stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $71.11M for Aquinox Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Aquinox Pharma Cash Flow